To Mammogram or not to Mammogram, and when?

Article

News summary of the discussion about when routine mammography screening for breast cancer should begin

The US Preventive Services Task Force issued a report recommending “against routine screening mammography in women aged 40-49 years”. As noted on its website, the USPSTF is an independent panel of private-sector experts in prevention and primary care.

Despite this recommendation the American Cancer Society is not changing its guideline and "continues to recommend annual screening using mammography and clinical breast examination for all women beginning at age 40". The full text of the response can be found here.

 

Related Clinical Links

 

Clinical News

 

What Your Patients are Reading

Recent Videos
Data from the SPOTLIGHT and GLOW trials reveal that zolbetuximab increased survival in patients with CLDN18.2-positive gastric or GEJ adenocarcinoma.
The incorporation of zolbetuximab in addition to chemotherapy has shown benefit in patients with Claudin 18.2–positive gastric cancers in clinical trials.
Michael J. Hall, MD, MS, FASCO, discusses the need to reduce barriers to care for those with Li-Fraumeni syndrome, including those who live in rural areas.
Patrick Oh, MD, highlights next steps for further research in treating patients with systemic therapy in addition to radiotherapy for early-stage NSCLC.
The ability of metformin to disrupt mitochondrial metabolism may help mitigate the risk of cancer in patients with Li-Fraumeni syndrome.
Related Content